Adalimumab-induced IgA nephropathy

Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan

doi:10.1136/bcr-2018-226442

Article info

Unexpected outcome (positive or negative) including adverse drug reactions

CASE REPORT

Adalimumab-induced IgA nephropathy

Authors

Aneesha Kaur Bhagat Singh Internal Medicine, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia Faculty of Medicine, University of Queensland, Herston, Queensland, Australia PubMed articles Google scholar articles
Andrew Sujeevan Jeyaruban Department of Medicine, Liverpool Hospital, NSW, Liverpool, New South Wales, Australia PubMed articles Google scholar articles
Gregory John Wilson Renal, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia PubMed articles Google scholar articles
Dwarakanathan Ranganathan Renal, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia School of Medicine, Griffith University, Gold Coast, Queensland, Australia PubMed articles Google scholar articles

Correspondence to Dr Aneesha Kaur Bhagat Singh, aneeshakaur89{at}yahoo.com

View Full Text

Citation

Bhagat Singh AK, Jeyaruban AS, Wilson GJ, et al

Adalimumab-induced IgA nephropathy

BMJ Case Reports CP 2019;12:e226442.

Publication history

Accepted February 12, 2019
First published March 31, 2019.

Online issue publication

March 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password